Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
Author(s) -
Marine Bruand,
David Barras,
Marco Mina,
Eleonora Ghisoni,
Matteo Morotti,
Evripidis Lanitis,
Noémie Fahr,
Mathieu Desbuisson,
Alizée J. Grimm,
Hualing Zhang,
Chloé Chong,
Julien Dagher,
Sora Chee,
Theodora Tsianou,
Julien Dorier,
Brian J. Stevenson,
Christian Iseli,
Catherine Ronet,
Sara Bobisse,
Raphaël Genolet,
Josephine Walton,
Michal BassaniSternberg,
Lana E. Kandalaft,
Bing Ren,
Iain A. McNeish,
Elizabeth M. Swisher,
Alexandre Harari,
Mauro Delorenzi,
Giovanni Ciriello,
Melita Irving,
Sylvie Rusakiewicz,
Periklis Foukas,
Fabio Marti,
Denarda Dangaj,
George Coukos
Publication year - 2021
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.109412
Subject(s) - cancer research , inflammation , biology , immune system , chemokine , immune checkpoint , immunotherapy , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom